Skip to content

The effect of dexmedetomidine versus saline placebo combined with esketamine on postpartum depression in patients undergoing cesarean section

The effect of dexmedetomidine on postpartum depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119312
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

NS+ESK group:Immediately after the delivery of the fetus, the parturient received a saline nasal spray, one spray in each nostril. Five minutes later, she was administered 0.2 mg/kg of esketamine intr
DEX+ESK group:Immediately after the fetus was delivered, the parturient received a nasal spray of dexmedetomidine, one spray in each nostril (25 µg per spray), and 5 minutes later, she was administere

Sponsors

Women and Children's Medical Center Affiliated to Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 - 45 years old; 2. Healthy singleton pregnancy; 3. Gestational age >= 37 weeks; 4. Height: 150 - 180 cm, BMI <= 34 kg/m^2; 5. ASA classification: Grade II; 6. All prenatal screening items for the fetus are normal; 7. The patient agrees to participate in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Had a history of emotional disorders (including depression) before pregnancy; 2. Had communication disorders; 3. Had severe pregnancy complications (such as preeclampsia, HELLP syndrome); 4. Had contraindications for esketamine (such as allergy to esketamine, refractory hypertension, cerebrovascular disease, cardiovascular disease or hyperthyroidism); 5. Had contraindications for Dexmedetomidine (such as allergy to Dexmedetomidine, heart rate < 50 beats per minute, or presence of cardiac conduction or rhythm abnormalities, preoperative systolic blood pressure < 90 mm Hg or diastolic blood pressure < 60 mm Hg); 6. ASA Level III or above

Design outcomes

Primary

MeasureTime frame
The positive rate of PPD on the 7th day after the operation;

Secondary

MeasureTime frame
EPDS(Edinburgh Postnatal Depression Scale) score;NRS(Numerical Rating Scale) score;The incidence of dissociation;Insomnia Severity Index(ISI);The time of the first postoperative defecation and flatus expulsion;Complications within 2 days after the operation;Newborn outcome;

Countries

China

Contacts

Public ContactMo Xiaofei

Women and Children's Medical Center Affiliated to Guangzhou Medical University

13560336485@163.com+86 135 6033 6485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026